MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 214 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q2 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $572,760 | -67.4% | 57,276 | -59.5% | 0.00% | -100.0% |
| Q2 2023 | $1,758,447 | +10.3% | 141,468 | +24.3% | 0.00% | 0.0% |
| Q1 2023 | $1,594,955 | +22.9% | 113,844 | +25.5% | 0.00% | – |
| Q4 2022 | $1,297,832 | -39.5% | 90,694 | +8.0% | 0.00% | -100.0% |
| Q3 2022 | $2,144,000 | -19.0% | 83,958 | -9.8% | 0.00% | 0.0% |
| Q2 2022 | $2,646,000 | -26.0% | 93,129 | -8.1% | 0.00% | 0.0% |
| Q1 2022 | $3,574,000 | -29.9% | 101,330 | -16.7% | 0.00% | 0.0% |
| Q4 2021 | $5,097,000 | -25.4% | 121,632 | -12.6% | 0.00% | -50.0% |
| Q3 2021 | $6,831,000 | +8.7% | 139,186 | -7.6% | 0.00% | 0.0% |
| Q2 2021 | $6,287,000 | +151.0% | 150,667 | +114.3% | 0.00% | +100.0% |
| Q1 2021 | $2,505,000 | +149.0% | 70,298 | +96.0% | 0.00% | – |
| Q4 2020 | $1,006,000 | – | 35,875 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $216,810,330 | 13.15% |
| 12 West Capital Management LP | 6,463,111 | $64,631,110 | 5.85% |
| Alpine Peaks Capital, LP | 359,300 | $3,593,000 | 2.50% |
| Connacht Asset Management LP | 24,155 | $241,550 | 1.43% |
| QVIDTVM Management LLC | 163,230 | $1,632,300 | 1.27% |
| BRAIDWELL LP | 3,974,857 | $39,748,570 | 1.26% |
| Mesirow Institutional Investment Management, Inc. | 926,277 | $9,262,770 | 0.94% |
| Granite Investment Partners, LLC | 1,488,359 | $14,883,590 | 0.62% |
| CARLSON CAPITAL L P | 635,000 | $6,350,000 | 0.50% |
| Pier Capital, LLC | 290,563 | $2,905,630 | 0.47% |